This Article Full Text Full Text (PDF) All Versions of this Article: 90/9/5478    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Locatelli, M. Articles by Laws, E. R. Search for Related Content PubMed PubMed Citation Articles by Locatelli, M. Articles by Laws, E. R. Related Collections Adrenal and Hypertension Neuroendocrinology and Pituitary

CLINICAL REVIEW: The Strategy of Immediate Reoperation for Transsphenoidal Surgery for Cushing’s Disease

Department of Neurosciences, Ospedale Maggiore Policlinico, IRCCS (M.L.), 20122 Milan, Italy; and Department of Neurological Surgery, Department of Internal Medicine-Endocrinology, University of Virginia Health Sciences Center (M.L.V., E.R.L.), Charlottesville, Virginia 22908-0212

Address all correspondence and requests for reprints to: Dr. Edward R. Laws, Neurosurgery, Box 800212, University of Virginia Health System, Charlottesville, Virginia 22908-0212. E-mail: el5g{at}virginia.edu.

Context: Transsphenoidal surgery is currently the primary therapeutic option for Cushing’s disease. Despite considerable initial success, 10–30% of patients fail to achieve lasting remission.

Evidence Acquisition: We evaluated a strategy of immediate reoperation in surgical failures judged by plasma cortisol levels that did not fall to 2 µg/dl or less within 72 h of surgery. Of 215 patients with presumed ACTH microadenomas, treated between 1993 and 2004, 12 met inclusion criteria and had prompt (within 15 d) reoperation for residual or missed ACTH microadenoma. These 12 patients represent 28% of those who did not have evidence of postoperative adrenal insufficiency.

Evidence Synthesis: Based on an outcome measure of sustained subnormal or normal plasma cortisol levels, eight of 12 patients (67%) achieved remission from the two operations. Adjunctive therapies (radiotherapy, gamma knife radiosurgery, and adrenalectomy) led to remission in another three patients. It is recognized that this outcome required either total hypophysectomy (one patient) or postoperative hypopituitarism (all patients in remission).

Conclusion: Magnetic resonance imaging was not usually helpful in determining therapeutic strategies; however, inferior petrosal sinus sampling was critical in providing confidence that the disease was of pituitary origin. A treatment algorithm is recommended, based on this study.

This article has been cited by other articles:

				C. G. Patil, D. M. Prevedello, S. P. Lad, M. L. Vance, M. O. Thorner, L. Katznelson, and E. R. Laws Jr. Late Recurrences of Cushing's Disease after Initial Successful Transsphenoidal Surgery J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 358 - 362. [Abstract] [Full Text] [PDF]

				N. Pouratian, D. M. Prevedello, J. Jagannathan, M. B. Lopes, M. L. Vance, and E. R. Laws Jr. Outcomes and Management of Patients with Cushing's Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3383 - 3388. [Abstract] [Full Text] [PDF]

				J. W. Findling and H. Raff Cushing's Syndrome: Important Issues in Diagnosis and Management J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3746 - 3753. [Abstract] [Full Text] [PDF]